Navigation Links
Northwestern to explore personalized medicine for scleroderma
Date:12/1/2011

CHICAGO --- Northwestern Medicine researchers have received two five-year grants totaling $953,000 from the National Institutes of Health's (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases to study scleroderma, an autoimmune disease for which there currently is no cure. The grants will enable researchers at Northwestern to identify biomarkers for the disease, and are the first step in developing a national resource for investigators studying scleroderma.

Scleroderma, also known as systemic sclerosis, is a chronic autoimmune disease in which the body's immune system attacks itself. It causes progressive thickening and tightening (fibrosis) of the skin and also can lead to serious internal organ damage and, in some cases, death.

Scleroderma affects an estimated 300,000 people in the United States, most frequently young to middle-aged women.

"These are game-changing grants for scleroderma research," said John Varga, M.D., professor of medicine and of dermatology at Northwestern University Feinberg School of Medicine and a physician at Northwestern Memorial Hospital. "They will greatly accelerate research into understanding fibrosis and its causes, and will move us toward personalized medicine for this complex disease."

Northwestern is one of four sites, along with Boston University School of Medicine, Dartmouth School of Medicine and University of Pittsburgh Medical Center, to receive funding through the new NIH grants. Northwestern will serve as the lead institution for proteomics research a fairly new area of biological study among this group, and will explore biomarkers at the protein level. These grants mark the first time large-scale proteomics will be applied to scleroderma research.

Early identification of biomarkers would potentially permit the development of more targeted therapies, noted Monique Hinchcliff, M.D., co-investigator and assistant professor of medicine at Feinberg.

"These grants allow researchers to use advanced techniques to study a very large and geographically diverse patient population at the molecular level," Hinchcliff said.


'/>"/>
Contact: Marla Paul
marla-paul@northwestern.edu
312-503-8928
Northwestern University
Source:Eurekalert

Related medicine news :

1. Lung cancer patients are the centerpiece for Northwestern medicine quality of care study
2. Northwestern Memorial maintains top status in nursing hospital renewed for Nurse Magnet®
3. Northwestern Medicine multiple sclerosis program earns national designation
4. Explorers Bounty Puffed Fruit Snacks Helping Parents Battle Summer Obesity
5. Pittsburgh Neurosurgeons Explore Use of Drug that Illuminates Brain Tumor Cells To Guide Surgery
6. Unusual Place to Find Peace, Bliss and Explore Life's Mysteries
7. GE Healthcare, Intel and Mayo Clinic explore new models of health care delivery
8. DSM Personalized Nutrition Webinar Explores Benefits of Nutrition for Employee Health
9. Explore, Love, Happiness, Life Purpose, and Destiny with World Renowned Yogi and Mystic, Sadhguru
10. Lung cancer research explores the effects of patient attitudes on patient outcomes
11. Top Scientists Explore the Origin of Life in Annual Lasker Lecture at Scripps Research Institute Florida Campus
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... April 28, 2017 , ... Early ... substantially improve drug safety and minimize the cost of development. In this webinar, ... inhibition using cell lines and for cardiac toxicity using induced pluripotent stem cells ...
(Date:4/28/2017)... ... April 28, 2017 , ... Researchers at Moffitt ... ActiGraph’s CentrePoint Data Hub in a sample of participants enrolled in an ... and sleep monitoring solutions for the global scientific community. The company’s new CentrePoint ...
(Date:4/28/2017)... , ... April 28, 2017 , ... NuevaCare, a leading ... diverse as Millbrae, Burlingame, and Palo Alto, is proud to announce information upgrades to ... to bookmark and read organized content on topics such as home care (generally) as ...
(Date:4/27/2017)... (PRWEB) , ... April 27, 2017 , ... ... nation’s leading respiratory hospital, based in Denver, Colorado, announced an agreement to create ... by the continuing support of the Jane and Leonard Korman Family Foundation. The ...
(Date:4/27/2017)... ... April 27, 2017 , ... ... Gasby the 2017 Public Leadership in Neurology Award (PLINA). The couple joins a ... Tedy Bruschi, Vice President Walter Mondale, actor Michael J. Fox and former U.S. ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... -- Research and Markets has announced the ... Prospects: Addressing Production Complexities Through Risk Management and Quality ... ... and Market Prospects: Overcoming Production Complexities Through Risk Management ... the current trends in the global biosimilars market, with ...
(Date:4/20/2017)... ZappRx, Inc ., a digital health company focused on modernizing ... closed $25 million in Series B funding led by Qiming ... Seattle that is part of a broader ... round included participation from SR One , who led ... (formerly Google Ventures). As part of the financing, Mark ...
(Date:4/20/2017)... 20, 2017 NeuroVive Pharmaceutical AB (Nasdaq ... positive preclinical results demonstrating anti-fibrotic effects with ... steatohepatitis (NASH), in an additional well-validated experimental ... has previously shown similar anti-fibrotic effects in ... scientists present novel data demonstrating anti-fibrotic effects ...
Breaking Medicine Technology: